Drake & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $702K | Buy |
900
+54
| +6% | +$42.1K | 0.17% | 59 |
|
|
2025
Q1 | $699K | Buy |
846
+113
| +15% | +$93.4K | 0.2% | 49 |
|
|
2024
Q4 | $644K | Sell |
733
-646
| -47% | -$568K | 0.18% | 51 |
|
|
2024
Q3 | $1.22M | Buy |
1,379
+133
| +11% | +$118K | 0.39% | 23 |
|
|
2024
Q2 | $1.13M | Sell |
1,246
-113
| -8% | -$102K | 0.4% | 22 |
|
|
2024
Q1 | $1.06M | Buy |
1,359
+15
| +1% | +$11.7K | 0.39% | 24 |
|
|
2023
Q4 | $784K | Sell |
1,344
-436
| -24% | -$254K | 0.32% | 25 |
|
|
2023
Q3 | $956K | Buy |
1,780
+24
| +1% | +$12.9K | 0.43% | 23 |
|
|
2023
Q2 | $824K | Sell |
1,756
-24
| -1% | -$11.3K | 0.37% | 23 |
|
|
2023
Q1 | $611K | Buy |
1,780
+47
| +3% | +$16.1K | 0.3% | 28 |
|
|
2022
Q4 | $634K | Buy |
1,733
+83
| +5% | +$30.4K | 0.34% | 24 |
|
|
2022
Q3 | $534K | Buy |
1,650
+661
| +67% | +$214K | 0.3% | 21 |
|
|
2022
Q2 | $321K | Buy |
+989
| New | +$321K | 0.18% | 32 |
|